Skip to main content
TipRanks
Go Ultimate75% OFF

Energenesis Biomedical Co., Ltd. (6657) Cash flow

Energenesis Biomedical Co., Ltd. Cash Flow

TW:6657's free cash flow for Q2 2026 was NT$-96.33M. For the 2026 fiscal year, TW:6657's free cash flow was decreased by NT$-432.00K and operating cash flow was NT$-95.90M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -222.41MNT$ -180.71MNT$ -225.05MNT$ -232.84MNT$ -97.29M
NT$ 91.83MNT$ 193.23MNT$ -58.96MNT$ 175.42MNT$ -115.76M
NT$ 399.34MNT$ 145.28MNT$ 440.42MNT$ -1.75MNT$ 287.98M
NT$ 673.10MNT$ 404.51MNT$ 246.61MNT$ 90.19MNT$ 149.37M
NT$ -224.72MNT$ -181.47MNT$ -225.89MNT$ -239.43MNT$ -106.18M

Currency in TWD

Energenesis Biomedical Co., Ltd. Cash Flow

-400M-200M0200M400M600M2019202020212022202320242025OperatingInvestingFinancing